牛牛AI助理已提取核心訊息
AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
根據最近的一份文件，艾伯維公司高管佩裏·西亞蒂亞斯定於2024年2月23日出售該公司13,753股普通股。這些股票價值約244萬美元，於同日通過行使股票期權收購。該交易涉及Siatias向發行人支付的現金。此次計劃出售是在過去三個月中進行的一筆交易之後進行的，當時西亞蒂亞斯出售了2,919股股票，總收益爲496,230美元。
根據最近的一份文件，艾伯維公司高管佩裏·西亞蒂亞斯定於2024年2月23日出售該公司13,753股普通股。這些股票價值約244萬美元，於同日通過行使股票期權收購。該交易涉及Siatias向發行人支付的現金。此次計劃出售是在過去三個月中進行的一筆交易之後進行的，當時西亞蒂亞斯出售了2,919股股票，總收益爲496,230美元。
有用
沒用
該公告為獨立文件：